1.0Probiomics S.r.l.https://probiomics.it/en/diego.vagnolihttps://probiomics.it/en/author/diego-vagnoli/Funded Project – PRE-SEED Plus - Probiomics S.r.l.rich600338<blockquote class="wp-embedded-content" data-secret="obnIZtGSPl"><a href="https://probiomics.it/en/funded-project-pre-seed-plus/">Funded Project – PRE-SEED Plus</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://probiomics.it/en/funded-project-pre-seed-plus/embed/#?secret=obnIZtGSPl" width="600" height="338" title="“Funded Project – PRE-SEED Plus” — Probiomics S.r.l." data-secret="obnIZtGSPl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://probiomics.it/wp-includes/js/wp-embed.min.js
</script>
Probiomics is a beneficiary of the Lazio Innova “PRE-SEED Plus” grant (PR FESR 2021–2027) for the development of the “Re-Clinic” project. The Re-Clinic project was created to enable pharmaceutical companies, IRCCS and research centres to access advanced omics analysis services compliant with GCLP standards. By integrating Proximity Extension Assay (PEA) technology into this workflow, our […]https://probiomics.it/wp-content/uploads/2026/03/istituzioni-pre-seed-lazio-innova.png1024150